Literature DB >> 9598320

DLG3, the gene encoding human neuroendocrine Dlg (NE-Dlg), is located within the 1.8-Mb dystonia-parkinsonism region at Xq13.1.

D G Stathakis1, D Lee, P J Bryant.   

Abstract

Neuroendocrine-Dlg (NE-Dlg) is a member of the discs-large-related (DLG) subfamily of the membrane-associated guanylate kinase-related protein family. Based on evidence from model systems, this protein appears to be critical for synaptogenesis, acting as a site-specific organizational center for integral membrane proteins and their downstream signaling molecules associated with the cytoskeleton. NE-Dlg also directly interacts with the colorectal tumor suppressor adenomatous polyposis coli, suggesting that it may play a role in regulating cell proliferation in epithelial cells. To explore the genetic control of NE-Dlg, we developed a physical map of the chromosome region containing DLG3, the locus encoding NE-Dlg. Using human-hamster radiation hybrid mapping panels, we mapped DLG3 to Xq13.1 and established a sequence-tagged site marker map of the surrounding region. We then developed a yeast artificial chromosome (YAC) contig for this region. Encompassing approximately 2.0 Mb contained within five overlapping YACs, this contig also includes the dystonia-parkinsonism syndrome (DYT3) locus. The close proximity of DLG3 to the DYT3 region suggests that the gene encoding NE-Dlg is a candidate locus for this neurological disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598320     DOI: 10.1006/geno.1998.5243

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivity.

Authors:  Eric R Gamazon; Hae Kyung Im; Peter H O'Donnell; Dana Ziliak; Amy L Stark; Nancy J Cox; M Eileen Dolan; Rong Stephanie Huang
Journal:  Mol Cancer Ther       Date:  2011-01-20       Impact factor: 6.261

2.  Two unrelated patients with inversions of the X chromosome and non-specific mental retardation: physical and transcriptional mapping of their common breakpoint region in Xq13.1.

Authors:  L Villard; S Briault; A M Lossi; C Paringaux; J Belougne; L Colleaux; D R Pincus; E Woollatt; J Lespinasse; A Munnich; C Moraine; M Fontès; J Gecz
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

3.  High expression of DLG3 is associated with decreased survival from breast cancer.

Authors:  Jie Liu; Pingping Li; Ruiqi Wang; Juan Li; Miao Zhang; Zhangjun Song; Peijun Liu
Journal:  Clin Exp Pharmacol Physiol       Date:  2019-07-31       Impact factor: 2.557

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.